Molecular Alterations Associated With Resistance to Endocrine Therapy and Impacting Treatment With mTOR Inhibitor
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: PROCEDURE: Biopsy
Sponsor: UNICANCER
Collaborators: Novartis|Fondation ARC